FLGT News and Press, Fulgent Genetics Inc. From 03/10/20

TEMPLE CITY, Calif., March 10, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (“NGS”) solutions, today announced the pr...

Many high-growth companies choose to sacrifice near-term profitability in order to drive as much revenue growth as possible. While that tradeoff can work out well for shareholders in some cases -- pull up any long-term chart of Amazon.com for proof -- the lack of profits tends to amp up t...

Healthcare Pulse Source: Bloomberg The fear of Coronavirus (Covid-19) has infected the stock market. The market's patience completely ran out this week as the Coronavirus news, which has continued to weigh heavily on the negative side, sent the market reeling in a feral pullback. Wha...

TEMPLE CITY, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its fourth quarter and full year 2019 financial results after the market closes on Tuesday Marc...

In this episode of Industry Focus: Wild Card Wednesday , Dylan Lewis and Brian Feroldi take a deep dive into Semler Scientific (OTC: SMLR) , LeMaitre Vascular (NASDAQ: LMAT) , and Fulgent Genetics (NASDAQ: FLGT) . Semler Scientific has a revolutionary new device with high accuracy...

Healthcare Pulse The market doesn't like uncertainty. And when you think about healthcare, that uncertainty is immediately magnified. Fundamentally, healthcare couldn't be better positioned, with an aging America, rapidly advancing therapies, a faster-moving FDA, easy access to risk capi...

Source: GraycellAdvisors.com Systematic Investing Systematic investing has become a growing part of the stock market. The investing style refers to a rules-based algorithmic system that limits or eliminates individual judgments and biases towards portfolio selection and adjustments. ...

TEMPLE CITY, Calif., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (NGS) solutions, today announced that its Chairman and C...

VistaGen Therapeutics (NASDAQ: VTGN ) -67%  on reporting Phase 2 results for AV-101 as a treatment of major depressive disorder. More news on: VistaGen Therapeutics, Inc., Pacific Coast Oil Trust, Ideanomics, Inc., Stocks on the move, Read more ...

Thinly traded micro cap Fulgent Genetics (NASDAQ: FLGT ) is down  12%  premarket on modest volume in reaction to its public offering of ~2.3M common shares at $11.25 per share. More news on: Fulgent Genetics, Inc., Healthcare stocks news, Stocks on the move, Read more ...